Funding Agreements Cover Up to 85% of Clinical Trials Costs
Filed with ASX ·
6ix is reading this filing.
Earlier from Invion
- Recruitment Conclusion for Ph 1 NMSC Trial & Advance to Ph 2
- Appendix 4C and Quarterly Activities Report - June 2026
- Photosoft Platform Expands to Eye Diseases Via Partnership
- Appendix 4C and Quarterly Activities Report - March 2026
- Skin Cancer Trial Moves to BCC With More Encouraging Signals
Follow Invion into a list and get an email when it puts out news.
Follow Invion